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Extensive data on the glycosaminoglycan (GAG) composition and the collagen fibril diameter distribution 
have been collected for a diverse range of connective tissues. It is shown that tissues with the smallest 
diameter collagen fibrils (mass-average diameter < 60 nm) have high concentrations of hyaluronic acid and 
that tissues with the largest diameter collagen fibrils (mass-average diameter -200nm) have high 
concentrations of dermatan sulphate. It is suggested that the lateral growth of fibrils beyond a diameter 
of about 60nm is inhibited by the presence of an excess of hyaluronic acid but that this inhibitory effect 
may be removed by an increasing concentration of chondroitin sulphate and/or dermatan sulphate. It is 
also postulated that high concentrations of chondroitin sulphate will inhibit fibril growth beyond a mass- 
average diameter of -150nm. Such an inhibition may in turn be removed by an increasing concentration 
of dermatan sulphate such that it becomes the dominant GAG present in the tissue. 
Glycosaminoglycan Collagen fibriI Fibrillogenesis Connective tissue development 
1. INTRODUCTION 
Although there have been extensive studies on 
the in vitro assembly of collagen molecules into a 
fibrillar form in the presence of various glycos- 
aminoglycans (GAGS) alone or in combination 
[l-12], the disparate results of these studies have 
made it difficult to assign a definitive role for the 
individual GAGS during either collagen fibrillo- 
genesis or fibril growth. It has been suggested that 
the duration of the so-called ‘lag (or nucleation) 
phase’ of fibril growth, which is altered by the 
presence of different GAGS, would directly affect 
the number-density of collagen fibrils so formed, 
in that collagen fibrils of smaller diameters would 
be produced when the nucleation phase was long 
and those of larger diameters when the nucleation 
phase was short [7-9,131. However, other ex- 
periments have shown that collagen molecules are 
capable of aggregating into fibrils in the absence of 
any of the GAGS [4,7,11] and that fibril diameter 
may be dependent upon glycoprotein content [ 141, 
parameters such as pH, ionic strength and 
temperature [3,15-181, the distribution and 
number of glycosylated residues along the length 
of the collagen molecule [ 191, the degree of 
copolymerisation in some tissues of types I and III 
collagen [20-211, collagen-fibronectin interac- 
tions [22] and the amount of collagen extension 
aminopropeptides remaining in the fibril [23]. 
In spite of these extensive data, there is as yet lit- 
tle understanding of the precise nature of collagen 
fibril assembly and growth in vivo. For this reason 
we have studied the relationship between collagen 
fibril diameter and GAG content of a variety of 
mammalian tissues at various stages of develop- 
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ment and, as a result, have attempted to formulate 
a new hypothesis of collagen fibrillogenesis and 
growth. However, at the outset we would em- 
phasise that we are aware of an inherent limitation 
in our analysis in that technological considerations 
have limited our studies to the glycosaminoglycans 
rather than to the true functional unit, the 
proteoglycan. 
2. HYPOTHESIS 
In table 1 we report the mass-average diameters 
of the collagen fibrils and the GAG content from 
a diversity of connective tissues at different ages. 
These data have been examined to determine 
whether there are any correlations between the 
GAG compositions and the mass-average dia- 
meters of the collagen fibrils. No simple (linear) 
relationships have been found, but when the in- 
dividual GAGS were expressed as a fraction of the 
total glycosaminoglycan pool it was noted that 
tissues containing the smallest fibrils frequently 
had the highest hyaluronic acid levels, those con- 
taining fibrils of intermediate size (mass-average 
diameter of 60-l 50 nm) had elevated choindroitin 
sulphate levels, and those with the largest diameter 
collagen fibrils contained the highest levels of der- 
matan sulphate (fig. 1). 
It has long been established that hyaluronic acid 
is the predominant GAG synthesized by foetal con- 
nective tissue cells both in vivo and in vitro [19,24] 
and in connective tissue regeneration and remodel- 
ling following wounding [19,25-261. It has been 
suggested that hyaluronic acid allows, or at least 
facilitates the migration of cells to sites of connec- 
tive tissue development or repair [27-291. As these 
are also areas of potential collagen synthesis it may 
be that hyaluronic acid, by virtue of its water- 
inclusion properties, could also facilitate the move- 
ment and distribution of newly synthesised col- 
lagen molecules and fibrils. In these situations, in 
which the primary stage of fibril growth is occur- 
ring, we postulate that the transverse or cir- 
cumferential growth of collagen fibrils is limited by 
the hyaluronic acid rich matrix so that only small 
fibrils < 60nm in diameter are formed. However, 
whilst hyaluronic acid, which does not bind to col- 
lagen under physiological conditions [ 10,30-321 
may inhibit lateral growth of the fibrils beyond 
60nm diameter, there is no comparable inhibition 
4 
I 1 
(a) 
(b) 
- &I . li0 . 180 - 240 . 360 * 360 
Mass-average diameter (nm) 
Fig. 1. The mean percentage contents of: (a) hyaluronic 
acid, (b) choindroitin sulphate, (c) dermatan sulphate 
from various tissues of diverse ages are plotted as a 
function of the mass-average diameter (nm) of the 
constitutent collagen fibrils. Such diameters have been 
grouped into 30nm intervals, and the mean values of the 
corresponding GAG contents are shown with limits of 
f 1 SD. The number of values (n) from which each mean 
value was determined is shown in (c). Two of the three 
data points for the interval O-29nm correspond to 
vitreous humour and synovial fluid which contain small 
diameter collagen fibrils (-10 nm diameter and -100% 
hyaluronic acid (G.C. Gillard, personal communication). 
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of longitudinal growth during this initial stage of 
fibrillogenesis [33]. Thus the tissue may lengthen 
and grow without the inherent restriction imposed 
by the presence of thicker fibrils. This mechanism 
does not imply that hyaluronic acid has a direct 
role as a nucleating agent; indeed it has already 
been noted that neither hyaluronic acid nor the 
other GAGS are essential for initiating the forma- 
tion of collagen fibrils in vitro. 
During maturation, the hyaluronic acid content 
of many connective tissues tends to decrease quite 
rapidly whilst the chondroitin sulphate and der- 
matan sulphate contents tend to increase from the 
low levels normally present during early foetal 
development. We propose that during this second 
stage of fibril development he inhibition of the 
lateral growth of fibrils imposed by the hyaluronic 
acid is removed by the proportionate increase of 
chondroitin sulphate [34] and/or dermatan 
sulphate synthesised preferentially by the cells in 
response to their changing mechanical or 
microelectrical environment [35,36]. Chondroitin 
sulphate, unlike hyaluronic acid, establishes weak 
inonic interactions with collagen under 
physiological conditions. We postulate that 
although this allows the development of larger 
diameter collagen fibrils, chondroitin sulphate 
itself will have an inhibitory effect on fibril growth 
beyond a diameter of about 150 nm. 
Other tissues, especially those which are sub- 
jected to high tensile stresses, experience a third 
stage of development in which the tissue is 
characterised by an increased percentage of der- 
matan sulphate and a marked increase in fibril 
diameter. We believe that as a result of the strong 
ionic interaction between dermatan sulphate and 
collagen under physiological conditions, an in- 
creasing proportion of dermatan sulphate may 
remove the inhibition of fibril growth imposed at 
the earlier stages of development and hence allow 
the collagen fibrils to grow laterally [33] to those 
sizes required for their increased tensile loading 
[37] (mass-average diameters > 150nm and 
typically -170-240nm). Although dermatan 
sulphate and chondroitin sulphate have the same 
charge density, dermatan sulphate appears to have 
a greater charge availability probably due to the 
presence of L-iduronic acid [31] and this may 
explain why it is capable of forming a stronger 
interaction with collagen. 
We envisage that the scheme of fibrillogenesis 
that we have postulated is sequential; the tissues 
containing the largest collagen fibrils (e.g., some 
tendons) must pass through a hyaluronic acid-rich 
stage, a chondroitin sulphate- and/or dermatan 
sulphate-rich stage but ultimately a dermatan 
sulphate rich stage. However, whereas tissues with 
collagen fibrils of mass-average diameter -200 nm 
can be predicted to have a high dermatan sulphate 
content, the converse cannot necessarily be assum- 
ed; i.e., a dominance of dermatan sulphate does 
not automatically favour the deposition of large 
diameter collagen fibrils unless the hyaluronic acid 
rich and the chondroitin sulphate- and/or der- 
matan sulphate-rich stages have occurred previous- 
ly and in that sequence. 
A special case exists for cornea but one which 
might nevertheless be similar in most respects to 
the scheme already suggested. In cornea, both cor- 
neal keratan sulphate and chondroitin sulphate are 
synthesised after the initial hyaluronic acid rich 
stage of development. The maintenance of 
uniform and small diameter collagen fibrils in cor- 
nea (-17 or 25nm; [38]), in spite of the presence 
of a significant proportion of chondroitin 
sulphate, is probably associated with the unique 
physico-chemical properties of cornea1 keratan 
sulphate, which would appear to restrict fibril 
growth absolutely. Cornea1 keratan sulphate is 
similar to hyaluronic acid in that neither interact 
with collagen under physiologocial conditions 
[30-321. Cornea1 scars, in which the cornea1 
keratan sulphate is largely replaced by dermatan 
sulphate, contain larger diameter collagen fibrils 
than occur in normal cornea [19,39]. 
3. DISCUSSION 
Let us now consider some of the data which is 
not included in table 1 but which provides support 
for the hypothesis outlined. Vitreous humour, 
synovial fluid and umbilical cord (as well as 
paratenon) are tissues which always contain a very 
high proportion of hyaluronic acid (260%) and 
which, as predicted, contain only small diameter 
fibrils (mass-average diameters -10-50 nm). We 
also note that cartilage and bone, which contain 
predominantly chondroitin sulphate, have small 
to moderately sized fibrils with mass-average 
diameters -40-80 nm at maturity. 
5 
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Establishing a correlation between collagen fibril 
diameter in skin and GAG composition is inherent- 
ly difficult. It is known that GAG composition 
changes with depth in the dermis [40,41] and that 
differential functional loading across the body of 
the animal results in local variations in fibril 
diameter distribution. However, the superficial 
(papillary) layer of the dermis of many animals 
(calf [40], human and pig [41]) has a higher GAG 
content, finer diameter collagen fibrils and a 
greater ratio of hyaluronic acid to dermatan 
sulphate than the deeper dermis. Also the 
perivascular and perifollicular zones of the dermis, 
which are associated with an hyaluronic acid-rich 
matrix, contain only small diameter collagen 
fibrils. These observations are predictable within 
the framework of the hypothesis. 
Dupuytren’s contracture (a pathological condi- 
tion of human palmar subdermis and fascia) con- 
tains only small diameter collagen fibrils 
(-40-50 nm diameter) even though both the chon- 
droitin sulphate and dermatan sulphate contents 
are high. A similar situation is found in another 
human pathological condition: hypertrophic scar- 
ring [42]. In both conditions the majority of col- 
lagen fibrils are of small diameters and are 
associated with high levels of chondroitin sulphate 
and low levels of hyaluronic acid compared with 
adjacent normal tissue. We may speculate that the 
omission of the hyaluronate rich stage from the 
onset of the pathological process has effectively 
prevented the formation of collagen fibrils of 
diameters 2 60 nm. 
Additional evidence in favour of the hypothesis 
comes from our observations [35,43] which show- 
ed that the rabbit flexor digitorum profundus ten- 
don (which curves around the back of the ankle) 
has markedly different chemical and structural 
features on the concave and convex sides. On the 
concave (pressure) side the GAG content is 
-2.3-3.5%, of which 60% is chondroitin 
sulphate, whilst the associated collagen fibrils have 
a mass-average diameter of -150nm; in the ten- 
sional parts of the tendon, the GAG content is 
-0.2% (70% being dermatan sulphate) and the 
fibrils have a mass-average diameter -200 nm [44]. 
It has also been found that if the tendon is 
translocated forward so that it is subjected only to 
tensional forces, profound biochemical and mor- 
phological changes occur [35,43,45]. In particular, 
6 
the cartilaginous pressure-bearing sesamoid region 
normally containing small diameter collagen fibrils 
and high levels of chondroitin sulphate is gradually 
replaced by normal tension-transmitting tendon 
with closely packed thick collagen fibrils associated 
with small amounts of GAG, of which a major 
proportion is now dermatan sulphate. This process 
can be reversed by repositioning the tendon at an 
appropriate time after initial translocation. Thus 
there is a reversible and concomitant change in 
fibril diameter and GAG composition when the 
physical environment of the cells is altered. It 
would thus seem possible that the growing collagen 
fibril can only sustain a particular diameter provid- 
ed that the appropriate GAG levels are maintained 
1461. 
Although the data presented in this work are 
consistent with the notion that the GAG composi- 
tion and the collagen fibril size are changing 
simultaneously (and not sequentially) as a result of 
(say) mechanical or microelectrical factors, we 
believe that this possibility is unlikely. It seems 
more probable to us that alterations in GAG com- 
position will precede collagen fibril diameter 
changes since the glycosaminoglycans turn over at 
a much greater rate than collagen. 
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